Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound

Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01208311

Enrollment

Registered

2010-09-23

Start date

2004-12-31

Completion date

2016-12-31

Last updated

2016-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism, Cirrhosis, Hepatitis c

Keywords

Alcoholic cirrhosis, hepatitis c cirrhosis, cirrhosis

Brief summary

The purpose of this study is to determine the amount of fibrosis in the liver of hepatitis C patients with advanced fibrosis, using endoscopic ultrasound.

Detailed description

Background: Transabdominal ultrasound cannot be used to quantitate fibrosis in patients with cirrhosis due to variability in the abdominal wall thickness and composition. This variability can be eliminated by using endoscopic ultrasound. Aim: To determine the amount of fibrosis in the liver of hepatitis C patients with advanced fibrosis, using endoscopic ultrasound.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* hepatic cirrhosis and hepatitis C and undergoing endoscopy * Alcoholic liver and undergoing endoscopy * Normal liver undergoing endoscopy

Exclusion criteria

* pregnancy * Children

Design outcomes

Primary

Measure	Time frame
Luminosity on ultrasound	Once at the time of the endoscopic ultrasound

Countries

United States

Outcome results